Safety and Immunogenicity of BNT162b2 in Antiretroviral Therapy-Treated People With HIV.

Mitha E, Berhe M, Aberg J, Lucasti CJ, Chalhoub F, Kitchin N, Vogler I, Lockhart SP, Fuchs S, Quandt J, Gruber WC, Webber C, Kühnle MC, Muik A, Lui BG, Vehreschild MJGT, Stephan C, Bushway M, Xu X, Belanger TJ, Trammel Price J, Liebscher S, Bailey R, Mather S, Adams EM, Shpyro S, Lagkadinou E, Türeci Ö, Swanson KA, Şahin U, Gurtman A

Open source

DOI: 10.1093/ofid/ofag310
Published: 2026 Jul
Container: Open forum infectious diseases
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ofid/ofag310,
  title = {Safety and Immunogenicity of BNT162b2 in Antiretroviral Therapy-Treated People With HIV.},
  author = {Mitha E and Berhe M and Aberg J and Lucasti CJ and Chalhoub F and Kitchin N and Vogler I and Lockhart SP and Fuchs S and Quandt J and Gruber WC and Webber C and Kühnle MC and Muik A and Lui BG and Vehreschild MJGT and Stephan C and Bushway M and Xu X and Belanger TJ and Trammel Price J and Liebscher S and Bailey R and Mather S and Adams EM and Shpyro S and Lagkadinou E and Türeci Ö and Swanson KA and Şahin U and Gurtman A},
  year = {2026},
  journal = {Open forum infectious diseases},
  doi = {10.1093/ofid/ofag310},
  url = {https://doi.org/10.1093/ofid/ofag310}
}

RIS

TY  - JOUR
TI  - Safety and Immunogenicity of BNT162b2 in Antiretroviral Therapy-Treated People With HIV.
AU  - Mitha E
AU  - Berhe M
AU  - Aberg J
AU  - Lucasti CJ
AU  - Chalhoub F
AU  - Kitchin N
AU  - Vogler I
AU  - Lockhart SP
AU  - Fuchs S
AU  - Quandt J
AU  - Gruber WC
AU  - Webber C
AU  - Kühnle MC
AU  - Muik A
AU  - Lui BG
AU  - Vehreschild MJGT
AU  - Stephan C
AU  - Bushway M
AU  - Xu X
AU  - Belanger TJ
AU  - Trammel Price J
AU  - Liebscher S
AU  - Bailey R
AU  - Mather S
AU  - Adams EM
AU  - Shpyro S
AU  - Lagkadinou E
AU  - Türeci Ö
AU  - Swanson KA
AU  - Şahin U
AU  - Gurtman A
PY  - 2026
JO  - Open forum infectious diseases
DO  - 10.1093/ofid/ofag310
UR  - https://doi.org/10.1093/ofid/ofag310
ER  -

APA

E, M., M, B., J, A., CJ, L., F, C., N, K., I, V., SP, L., S, F., J, Q., WC, G., C, W., MC, K., A, M., BG, L., MJGT, V., C, S., M, B., X, X., TJ, B., J, T. P., S, L., R, B., S, M., EM, A., S, S., E, L., Ö, T., KA, S., U, Ş., & A, G. (2026). Safety and Immunogenicity of BNT162b2 in Antiretroviral Therapy-Treated People With HIV.. Open forum infectious diseases. https://doi.org/10.1093/ofid/ofag310

Source records

pubmed · retrieved 2026-09-25T08:05:17.026Z